AGENUS INC Short-term Investments
AGENUS INC (AGEN) had Short-term Investments of $14.65 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2024-03-14
- 2023-06-30: Short-term Investments $14.65M.
- 2023-03-31: Short-term Investments $24.41M.
- 2022-12-31: Short-term Investments $14.68M.
- 2022-09-30: Short-term Investments $9.88M.
| Period end | Short-term Investments |
|---|---|
| 2023-06-30 | $14.65M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $24.41M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $14.68M 10-K · filed 2024-03-14 |
| 2022-09-30 | $9.88M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.95M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.98M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $14.99M 10-K · filed 2023-03-16 |
| 2021-09-30 | $5.00M 10-Q · filed 2021-11-09 |
| 2017-09-30 | $4.98M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $14.94M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $9.96M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $4.99M 10-K · filed 2018-03-16 |
| 2016-09-30 | $19.96M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $49.90M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $69.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $34.96M 10-K · filed 2017-03-16 |
| 2015-09-30 | $14.99M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $14.98M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 |
| 2014-12-31 | $14.51M 10-K · filed 2016-03-15 |
| 2014-09-30 | $14.52M 10-Q · filed 2014-10-31 |
| 2014-06-30 | $14.55M 10-Q · filed 2014-08-01 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-09 |
| 2011-12-31 | $0.00 10-Q · filed 2012-05-09 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-04 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |